ATC code - L01FX
Spain- L01FX02 1 drugs
- L01FX04 2 drugs
- L01FX05 1 drugs
- L01FX06 1 drugs
- L01FX07 1 drugs
- L01FX08 1 drugs
- L01FX09 1 drugs
- L01FX12 1 drugs
- L01FX13 2 drugs
- L01FX14 2 drugs
- L01FX17 1 drugs
- L01FX18 3 drugs
- L01FX20 1 drugs
- L01FX24 2 drugs
- L01FX25 2 drugs
- L01FX27 2 drugs
- L01FX28 2 drugs
- L01FX29 2 drugs
- L01FX32 1 drugs
Drugs with code L01FX
-
Form: powder for concentrate for solution for infusion
Active substance Dosage brentuximab vedotin 50 mg ATC code: L01F, L01FX, L01FX05
Manufacturer: Takeda Pharma A/S
-
Form: powder for concentrate and solution for infusion
Active substance Dosage blinatumomab 38,5 µg ATC code: L01F, L01FX, L01FX07
Manufacturer: Amgen Europe B.V.
-
Form: solution for infusion, concentrate
Active substance Dosage glofitamab 10 mg ATC code: L01F, L01FX, L01FX28
Manufacturer: Roche Registration Gmbh
-
Form: solution for infusion, concentrate
Active substance Dosage glofitamab 2,5 mg ATC code: L01F, L01FX, L01FX28
Manufacturer: Roche Registration Gmbh
-
Form: solution for injection
Active substance Dosage elranatamab 40 mg ATC code: L01F, L01FX, L01FX32
Manufacturer: Pfizer Europe Ma Eeig
-
Form: powder for concentrate for solution for infusion
Active substance Dosage elotuzumab 400 mg ATC code: L01F, L01FX, L01FX08
Manufacturer: Bristol-Myers Squibb Pharma Eeig
-
Form: solution for infusion, concentrate
Active substance Dosage tremelimumab 300 mg ATC code: L01F, L01FX, L01FX20
Manufacturer: Astrazeneca Ab
-
Form: solution for infusion, concentrate
Active substance Dosage mosunetuzumab 1 mg ATC code: L01F, L01FX, L01FX25
Manufacturer: Roche Registration Gmbh
-
Form: solution for infusion, concentrate
Active substance Dosage mosunetuzumab 30 mg ATC code: L01F, L01FX, L01FX25
Manufacturer: Roche Registration Gmbh
-
Form: powder for concentrate for solution for infusion
Active substance Dosage tafasitamab 200 mg ATC code: L01F, L01FX, L01FX12
Manufacturer: Incyte Biosciences Distribution B.V.
-
Form: powder for concentrate and solution for infusion
Active substance Dosage gemtuzumab ozogamicine 5 mg ATC code: L01F, L01FX, L01FX02
Manufacturer: Pfizer Europe Ma Eeig
-
Form: powder for concentrate for solution for infusion
Active substance Dosage enfortumab vedotin 20 mg ATC code: L01F, L01FX, L01FX13
Manufacturer: Astellas Pharma Europe B.V.
-
Form: powder for concentrate for solution for infusion
Active substance Dosage enfortumab vedotin 30 mg ATC code: L01F, L01FX, L01FX13
Manufacturer: Astellas Pharma Europe B.V.
-
Form: powder for concentrate for solution for infusion
Active substance Dosage polatuzumab vedotina 140 mg ATC code: L01F, L01FX, L01FX14
Manufacturer: Roche Registration Gmbh
-
Form: powder for concentrate for solution for infusion
Active substance Dosage polatuzumab vedotina 30 mg ATC code: L01F, L01FX, L01FX14
Manufacturer: Roche Registration Gmbh
-
Form: solution for infusion, concentrate
Active substance Dosage mogamulizumab 20 mg ATC code: L01F, L01FX, L01FX09
Manufacturer: Kyowa Kirin Holdings B.V.
-
Form: solution for infusion, concentrate
Active substance Dosage dinutuximab beta 4,5 mg ATC code: L01F, L01FX, L01FX06
Manufacturer: Recordati Netherlands B.V.
-
Form: solution for injection
Active substance Dosage amivantamab 1600 mg ATC code: L01F, L01FX, L01FX18
Manufacturer: Janssen-Cilag International N.V
-
Form: solution for injection
Active substance Dosage amivantamab 2240 mg ATC code: L01F, L01FX, L01FX18
Manufacturer: Janssen-Cilag International N.V
-
Form: solution for infusion, concentrate
Active substance Dosage amivantamab 350 mg ATC code: L01F, L01FX, L01FX18
Manufacturer: Janssen-Cilag International N.V
-
Form: solution for injection
Active substance Dosage talquetamab 3 mg ATC code: L01F, L01FX, L01FX29
Manufacturer: Janssen-Cilag International N.V
-
Form: solution for injection
Active substance Dosage talquetamab 40 mg ATC code: L01F, L01FX, L01FX29
Manufacturer: Janssen-Cilag International N.V
-
Form: solution for injection
Active substance Dosage teclistamab 30 mg ATC code: L01F, L01FX, L01FX24
Manufacturer: Janssen-Cilag International N.V
-
Form: solution for injection
Active substance Dosage teclistamab 153 mg ATC code: L01F, L01FX, L01FX24
Manufacturer: Janssen-Cilag International N.V
-
Form: solution for injection, concentrate
Active substance Dosage epcoritamab 5 mg/ml ATC code: L01F, L01FX, L01FX27
Manufacturer: Abbvie Deutschland Gmbh & Co. Kg
-
Form: solution for injection
Active substance Dosage epcoritamab 60 mg/ml ATC code: L01F, L01FX, L01FX27
Manufacturer: Abbvie Deutschland Gmbh & Co. Kg
-
Form: powder for concentrate for solution for infusion
Active substance Dosage sacituzumab govitecan 200 mg ATC code: L01F, L01FX, L01FX17
Manufacturer: Gilead Sciences Ireland Unlimited Company
-
Form: solution for infusion, concentrate
Active substance Dosage ipilimumab 53,5 mg ATC code: L01F, L01FX, L01FX04
Manufacturer: Bristol-Myers Squibb Pharma Eeig
-
Form: solution for infusion, concentrate
Active substance Dosage ipilimumab 213 mg ATC code: L01F, L01FX, L01FX04
Manufacturer: Bristol-Myers Squibb Pharma Eeig